AAAAAA

   
Results: 1-23 |
Results: 23
Development of virus-specific immune responses in SHIVKU-infected macaquestreated with PMPA
Authors: Kumar, A Buch, S Foresman, L Bischofberger, N Lifson, JD Narayan, O
Citation: A. Kumar et al., Development of virus-specific immune responses in SHIVKU-infected macaquestreated with PMPA, VIROLOGY, 279(1), 2001, pp. 97-108
Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected rhesus macaques after short-term antiretroviral treatment
Authors: Spring, M Stahl-Hennig, C Stolte, N Bischofberger, N Heeney, J ten Haaft, P Tenner-Racz, K Racz, P Lorenzen, D Hunsmann, G Dittmer, U
Citation: M. Spring et al., Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected rhesus macaques after short-term antiretroviral treatment, VIROLOGY, 279(1), 2001, pp. 221-232
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4(+) T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans
Authors: Igarashi, T Brown, CR Endo, Y Buckler-White, A Plishka, R Bischofberger, N Hirsch, V Martin, MA
Citation: T. Igarashi et al., Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4(+) T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans, P NAS US, 98(2), 2001, pp. 658-663
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment
Authors: Lifson, JD Rossio, JL Piatak, M Parks, T Li, L Kiser, R Coalter, V Fisher, B Flynn, BM Czajak, S Hirsch, VM Reimann, KA Schmitz, JE Ghrayeb, J Bischofberger, N Nowak, MA Desrosiers, RC Wodarz, D
Citation: Jd. Lifson et al., Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment, J VIROLOGY, 75(21), 2001, pp. 10187-10199
Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection
Authors: Van Rompay, KKA McChesney, MB Aguirre, NL Schmidt, KA Bischofberger, N Marthas, ML
Citation: Kka. Van Rompay et al., Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection, J INFEC DIS, 184(4), 2001, pp. 429-438
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques
Authors: Hel, Z Venzon, D Poudyal, M Tsai, WP Giuliani, L Woodward, R Chougnet, C Shearer, G Altman, JD Watkins, D Bischofberger, N Abimiku, A Markham, P Tartaglia, J Franchini, G
Citation: Z. Hel et al., Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques, NAT MED, 6(10), 2000, pp. 1140-1146
Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques
Authors: Silvera, P Racz, P Racz, K Bischofberger, N Crabbs, C Yalley-Ogunro, J Greenhouse, J Jiang, JB Lewis, MG
Citation: P. Silvera et al., Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques, AIDS RES H, 16(8), 2000, pp. 791-800
Recent developments in antiretroviral therapies
Authors: Cihlar, T Bischofberger, N
Citation: T. Cihlar et N. Bischofberger, Recent developments in antiretroviral therapies, ANNU REP M, 35, 2000, pp. 177-189
Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques asa model for protection from HIV infection
Authors: Tsai, CC Emau, P Sun, JC Beck, TW Tran, CA Follis, KE Bischofberger, N Morton, WR
Citation: Cc. Tsai et al., Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques asa model for protection from HIV infection, J MED PRIM, 29(3-4), 2000, pp. 248-258
Lasting effects of transient postinoculation tenofovir [9-R-(2-phosphonomethoxypropyl)adenine] treatment on SHIVKU2 infection of rhesus macaques
Authors: Smith, MS Foresman, L Lopez, GJ Tsay, J Wodarz, D Lifson, JD Page, A Wang, CY Li, Z Adany, I Buch, S Bischofberger, N Narayan, O
Citation: Ms. Smith et al., Lasting effects of transient postinoculation tenofovir [9-R-(2-phosphonomethoxypropyl)adenine] treatment on SHIVKU2 infection of rhesus macaques, VIROLOGY, 277(2), 2000, pp. 306-315
The origin and control of pandemic influenza
Authors: Laver, WG Bischofberger, N Webster, RG
Citation: Wg. Laver et al., The origin and control of pandemic influenza, PERSP BIOL, 43(2), 2000, pp. 173-192
Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculationantiretroviral treatment
Authors: Lifson, JD Rossio, JL Arnaout, R Li, L Parks, TL Schneider, DK Kiser, RF Coalter, VJ Walsh, G Imming, RJ Fisher, B Flynn, BM Bischofberger, N Piatak, M Hirsch, VM Nowak, MA Wodarz, D
Citation: Jd. Lifson et al., Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculationantiretroviral treatment, J VIROLOGY, 74(6), 2000, pp. 2584-2593
Antiretroviral therapy during primary immunodeficiency virus infection caninduce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques
Authors: Rosenwirth, B ten Haaft, P Bogers, WMJM Nieuwenhuis, IG Niphuis, H Kuhn, EM Bischofberger, N Heeney, JL Uberla, K
Citation: B. Rosenwirth et al., Antiretroviral therapy during primary immunodeficiency virus infection caninduce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques, J VIROLOGY, 74(4), 2000, pp. 1704-1711
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA
Authors: Van Rompay, KKA Miller, MD Marthas, ML Margot, NA Dailey, PJ Canfield, DR Tarara, RP Cherrington, JM Aguirre, NL Bischofberger, N Pedersen, NC
Citation: Kka. Van Rompay et al., Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA, J VIROLOGY, 74(4), 2000, pp. 1767-1774
Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys
Authors: Fox, HS Weed, MR Huitron-Resendiz, S Baig, J Horn, TFW Dailey, PJ Bischofberger, N Henriksen, SJ
Citation: Hs. Fox et al., Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys, J CLIN INV, 106(1), 2000, pp. 37-45
Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): Safety and efficacy studies
Authors: Tarantal, AF Marthas, ML Shaw, JP Cundy, K Bischofberger, N
Citation: Af. Tarantal et al., Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): Safety and efficacy studies, J ACQ IMM D, 20(4), 1999, pp. 323-333
9-[2-(phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA
Authors: Van Rompay, KKA Cherrington, JM Marthas, ML Lamy, PD Dailey, PJ Canfield, DR Tarara, RP Bischofberger, N Pedersen, NC
Citation: Kka. Van Rompay et al., 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA, ANTIM AG CH, 43(4), 1999, pp. 802-812
An anti-HIV strategy combining chemotherapy and therapeutic vaccination
Authors: Rosenwirth, B Bogers, WMJM Nieuwenhuis, IG Ten Haaft, P Niphuis, H Kuhn, EM Bischofberger, N Erfle, V Sutter, G Berglund, P Liljestrom, P Uberla, K Heeney, JL
Citation: B. Rosenwirth et al., An anti-HIV strategy combining chemotherapy and therapeutic vaccination, J MED PRIM, 28(4-5), 1999, pp. 195-205
Disarming flu viruses
Authors: Laver, WG Bischofberger, N Webster, RG
Citation: Wg. Laver et al., Disarming flu viruses, SCI AM, 280(1), 1999, pp. 78-87
Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques
Authors: Van Rompay, KKA Dailey, PJ Tarara, RP Canfield, DR Aguirre, NL Cherrington, JM Lamy, PD Bischofberger, N Pedersen, NC Marthas, ML
Citation: Kka. Van Rompay et al., Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques, J VIROLOGY, 73(4), 1999, pp. 2947-2955
Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBj
Authors: Hodge, S de Rosayro, J Glenn, A Ojukwu, IC Dewhurst, S McClure, HM Bischofberger, N Anderson, DC Klumpp, SA Novembre, FJ
Citation: S. Hodge et al., Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBj, J VIROLOGY, 73(10), 1999, pp. 8630-8639
Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A(1) receptor agonist
Authors: Von Lubitz, DKJE Lin, RCS Bischofberger, N Beenhakker, M Boyd, M Lipartowska, R Jacobson, KA
Citation: Dkje. Von Lubitz et al., Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A(1) receptor agonist, EUR J PHARM, 369(3), 1999, pp. 313-317
Chronic administration of adenosine A(3) receptor agonist and cerebral ischemia: neuronal and glial effects
Authors: Von Lubitz, DKJE Lin, RCS Boyd, M Bischofberger, N Jacobson, KA
Citation: Dkje. Von Lubitz et al., Chronic administration of adenosine A(3) receptor agonist and cerebral ischemia: neuronal and glial effects, EUR J PHARM, 367(2-3), 1999, pp. 157-163
Risultati: 1-23 |